Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Yposkesi, an SK pharmteco Company


26, rue Henri-Desbruères
91100 CORBEIL-ESSONNES – FRANCE
Phone: +33 1 61 61 70 01
Email: alamproye@yposkesi.com

Frédéric REVAH: President
Site Web >
Yposkesi, an SK pharmteco Company Yposkesi, an SK pharmteco Company

#Biomanufacturing / Pharmaceutical Services #Industrial Biotech

  • Rare diseases
  • Gene therapy
  • Cell therapy
  • Tissue replacement
  • GMPs
  • Contract Manufacturing

Field of Activity


Yposkesi, an SK pharmteco Company, is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

BACKGROUND

Created in November 2016 by AFM-Telethon and the SPI fund managed by Bpifrance, this new company aims to make gene and cell therapies available to patients at a fair and controlled price, in accordance with the commitment made by its founders.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

Activities:

  • Contract and development manufacturing organization (CDMO)
  • Contract manufacturing organization for gene and cell therapy products (pre-clinical and clinical batches).
  • Innovation and development of process and analytical technologies in the field of gene and cell therapy.

CUSTOMER REFERENCES /COLLABORATIONS / HIGHLIGHTS

Yposkesi is certified as a pharmaceutical establishment (medicinal product for humanuse) by ANSM, the French national agency for health product safety.
The strategy of Yposkesi is focused on extending production capacities through planned investments.

  • 1 large scale manufacturing unit for viral vectors (commercial), planned for 2021.
  • 1 R&D unit (process & analytical development) planned for 2018.
  • Modular cleanroom facilities for the GMP manufacturing of cell therapy products planned for 2021.
  • Further Information

    145 Staff members

    Strengths
    – Biggest European Project for the production of gene and cell therapies.
    – Broad epertise in the production process developmentand the associated control methods.

    Innovation Assets
    10% of Yposkesi human resources dedicated to innovation and development of new technologies.

Share
Genopole’s Companies

#Biomanufacturing / Pharmaceutical Services


In same field

Alt Biotech - Genopole's Company Gene.iO#3

Alt Biotech

Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact

Discover
Kyron.Bio - Genopole's Company

Kyron.Bio

Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

Discover
Nutropy - Genopole's company

Nutropy

Nutropy develops gourmet French cheese alternatives that are more sustainable and better for our health and animal welfare.

Discover
STH Biotech - Genopole's company

STH Biotech

STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.

Discover
Synovance - entreprise généopolitaine

Synovance

Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Discover
Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks

Altar

Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Texcell - Genopole's Company

Texcell

Texcell offers fully GLP- and GMP-compliant viral safety testing and immunomonitoring services.

Discover
Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

Discover
Genosafe - Genopole's Company

Genosafe

GenoSafe is a full contract research and consulting organization specialized in evaluating the quality, safety and efficacy of innovative biological products. Our goal is to enable our clients to move their products along clinical development rapidly and efficiently.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

Discover
View all >
With the support from
Région île de France